SCHEMBL18518273

SCHEMBL18518273

COc1ccc(-c2cc(-c3nn(C(C)C)c4ncnc(N)c34)no2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 11/20 0.78
▸ SRC P12931 9/20 0.71
▸ ABL1 P00519 7/20 0.71
▸ HCK P08631 7/20 0.71
▸ EGFR P00533 6/20 0.71
▸ KDR P35968 6/20 0.71
▸ PIK3CD O00329 5/20 0.71
▸ PIK3CA P42336 5/20 0.71
▸ PIK3CB P42338 5/20 0.71
▸ MTOR P42345 5/20 0.71
▸ PIK3CG P48736 5/20 0.71
▸ EPHB4 P54760 5/20 0.71
▸ PRKDC P78527 5/20 0.71
▸ PI4KB Q9UBF8 5/20 0.71
▸ LCK P06239 1/20 0.64
▸ EPHA3 P29320 1/20 0.64
▸ CSK P41240 1/20 0.64
▸ CYP1A2 P05177 1/20 0.59
▸ FGR P09769 1/20 0.59
▸ RPS6KB1 P23443 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18518395 0.88 RET (1.00) RETSRCABL1HCKEGFR
SCHEMBL18518409 0.88 RET (1.00) RETSRCABL1HCKEGFR
SCHEMBL29388399 0.84 SRC (1.00) SRCABL1HCKEGFRKDR
SCHEMBL2464370 0.84 SRC (1.00) SRCABL1HCKEGFRKDR
SCHEMBL18518389 0.83 RET (0.76) RETSRCABL1HCKEGFR
SCHEMBL18518586 0.81 RET (0.80) RETSRCABL1HCKEGFR
SCHEMBL18518397 0.81 RET (0.80) RETSRCABL1HCKEGFR
SCHEMBL18518418 0.80 RET (1.00) RETSRCABL1HCKEGFR
SCHEMBL12436124 0.79 SRC (1.00) SRCABL1HCKEGFRKDR
SCHEMBL29390313 0.79 SRC (1.00) SRCABL1HCKEGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017026718-A1 NOVEL 3-(ISOXAZOL-3-YL)-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE COMPOUND, WHICH IS RET KINASE INHIBITOR 한국과학기술연구원 2017-02-16 — — WO disclosed
Send feedback